Sign In

News Story

ACS CAN's 2017 advocacy accomplishments report now available

‚ÄčThe American Cancer Society Cancer Action Network's (ACS CAN) 2017 Advocacy Accomplishments report, "Cancer Advocacy: Leading a Movement to Promote and Preserve Progress," is now available online.

The report details ACS CAN's success at the local, state, and national levels of government.  In 2017, ACS CAN volunteers and staff celebrated a $2 billion increase in medical research funding for the National Institutes of Health (NIH), including $475 million for the National Cancer Institute (NCI) in the fiscal year (FY) 2017 budget. 

ACS CAN staff and volunteers continued to advocate for robust and sustained funding for critical cancer programs, and after the 2017 report went to press, Congress approved an FY 2018 spending bill that included a $3 billion increase for medical research, including cancer-focused grants. The largest increase for research in the federal budget in 15 years allowed ACS CAN to reach its One Degree campaign goal of increasing federal funding for medical research at NIH by $6 billion, including $1 billion for cancer-specific research at NCI. Fighting to preserve cancer research funding for FY 2019 will be a top priority for ACS CAN to continue to save more lives. 

ACS CAN staff and volunteers also secured a number of victories in tobacco control, including Aspen, CO's tobacco tax increase of $3 per pack and New York City's increase of the minimum price of cigarettes from $10.50 to $13.  Additionally, more than 2.7 million people will be covered by new local smoke-free laws that include restaurants and bars once all ordinances passed in 2017 are fully implemented. These are just some of the accomplishments featured in this year's report.

Please share the report with colleagues, volunteers, corporate partners, and others to increase awareness and understanding of ACS CAN's role in helping to achieve the American Cancer Society's mission to save lives, celebrate lives, and lead the fight for a world without cancer. 

 

 

 

 




back to top